Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Antidepressant Data Was Fully Disclosed, Agency Tells Congress

This article was originally published in The Pink Sheet Daily

Executive Summary

Although there was internal disagreement on the implications of pediatric antidepressant data, all information was reviewed publicly, the agency maintains in a letter to the House Energy & Commerce/Oversight Subcommittee.

You may also be interested in...



Antidepressant Makers Expected To Testify At Sept. 9 Hearing On Trial Data Disclosure

House Commerce/Oversight Subcommittee Vice Chairman Greg Walden will oversee discussion of FDA, industry handling of data on antidepressant-related pediatric suicides.

Antidepressant Makers Expected To Testify At Sept. 9 Hearing On Trial Data Disclosure

House Commerce/Oversight Subcommittee Vice Chairman Greg Walden will oversee discussion of FDA, industry handling of data on antidepressant-related pediatric suicides.

House Antidepressant Hearing Rescheduled For Sept. 9

The hearing was postponed from July 20 when former subcommittee Chairman Greenwood accepted a position as BIO president. Witnesses could include seven antidepressant manufacturers.

Related Content

Topics

UsernamePublicRestriction

Register

PS059117

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel